SpotitEarly develops scent based multi-cancer early detection screening test, combining proprietary AI stack with bio-detectors, to detect cancer at its early stages and save people’s lives. Spotitearly is currently conducting a large clinical trial for screening breast, lung, colon and prostate cancers in one test. During training phase, the test showed higher sensitivity and better specificity in detecting early stages of cancer compared to any existing test on the market today.